Human CD4‐8‐ ‐Derived Clones Phenotypic and Functional Characteristics and Variation between Donors in Patterns of T‐Cell Receptor y Gene Rearrangements
- 29 June 1989
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 29 (6) , 699-708
- https://doi.org/10.1111/j.1365-3083.1989.tb01174.x
Abstract
Clones were derived from highly purified human CD4‐8‐ lymphocytes from three different donors and maintained in the presence of interleukin 2 and phytohaemagglutinin. Considerable variation was noted between donors in the phenotype and T‐cell receptor (TCR) γ gene rearrangements of CD4‐8‐ ‐derived clones. In one donor, most clones remained CD4‐8‐ and all were CD3+WT31‐ and therefore expressed γ/δ heterodimers. TCR γ gene rearrangements almost all involved Cγ1. In contrast, most clones from a second donor were CD3+WT31‐, and therefore expressed α/β heterodimers, and many were positive for CD4 or CD8. Most clones from a third donor were CD3+ WT31‐ with a high proportion of TCRγ gene rearrangements involving Cγ2. The Vγ9JP rearrangement was exclusively confined to CD3+WT31‐ clones and was present in the majority of clones. Almost all CD3+WT31‐ clones showed TCR β as well as γ gene rearrangements. Most CD3+WT31‐ clones with at least one chromosome rearranged to Cγ1 exhibited high non‐major histocompatibility complex (MHC)‐restricted cytotoxic activity, while most of those with two Cγ2 rearrangements, and therefore expressing a non‐disulphide‐linked γ/δ heterodimer, had low activity. Preincubation of effector cells with anti‐CD3 strongly inhibited the cytotoxicity of CD3+WT31‐ clones while that of CD3+WT31‐ clones was enhanced. This implicates the CD3‐γ/δ complex in target cell recognition by cytotoxic γ/δ‐bearing T‐cell clones. The results show that there is heterogeneity between donors in the relative proportions of CD4‐8‐ ‐derived clones expressing α/β heterodimers and the different forms of the γ/δ heterodimer.This publication has 28 references indexed in Scilit:
- Characterization of a third form of the human T cell receptor gamma/delta.The Journal of Experimental Medicine, 1988
- Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.The Journal of Experimental Medicine, 1988
- A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).The Journal of Experimental Medicine, 1988
- Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.The Journal of Experimental Medicine, 1988
- A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes.The Journal of Experimental Medicine, 1988
- Rearrangements to the JP1, JP and JP2 segments in the human T‐cell rearranging gamma gene (TRGγ) locusFEBS Letters, 1987
- A novel subset of human lymphocytes with a T cell receptor-gamma complex.The Journal of Experimental Medicine, 1987
- Human CD3+4−8−WT31−T lymphocyte expressing the putative T cell receptor γ‐gene product. A limiting dilution and clonal analysisEuropean Journal of Immunology, 1987
- Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.The Journal of Experimental Medicine, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984